| Recruiting | Translation of Acoustic Angiography: Contrast Enhanced Super Resolution (CESR) Imaging NCT07225114 | UNC Lineberger Comprehensive Cancer Center | Phase 2 |
| Recruiting | CD70-targeted immunoPET Imaging of Kidney Cancer NCT06680089 | RenJi Hospital | Phase 2 |
| Recruiting | Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma NCT06676527 | Jinling Hospital, China | — |
| Recruiting | Planning Operative Strategy Using a Digital Renal Artery Clamping Tool NCT06536439 | University Hospital, Ghent | N/A |
| Recruiting | Zero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage NCT06715878 | RenJi Hospital | N/A |
| Terminated | Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccR NCT05935748 | NiKang Therapeutics, Inc. | Phase 2 |
| Recruiting | HTL0039732 in Participants With Advanced Solid Tumours NCT05944237 | Cancer Research UK | Phase 1 / Phase 2 |
| Completed | The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy NCT05432232 | HistoSonics, Inc. | N/A |
| Recruiting | Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) NCT05917106 | Jinling Hospital, China | — |
| Unknown | Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal Carcinoma NCT05790122 | The Fourth Affiliated Hospital of Zhejiang University School of Medicine | — |
| Completed | Clinical-pathological Characterization and Outcomes of Renal Cell Carcinoma in Latin American NCT05184504 | Latin American Cooperative Oncology Group | — |
| Completed | A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of So NCT05363072 | Pfizer | — |
| Terminated | A Study of NKT2152, a HIF2α Inhibitor, in Patients With Advanced Clear Cell Renal Cell Carcinoma NCT05119335 | NiKang Therapeutics, Inc. | Phase 1 / Phase 2 |
| Unknown | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients NCT05068180 | RenJi Hospital | Phase 4 |
| Completed | Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National NCT04669366 | Pfizer | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanc NCT04513522 | Bristol-Myers Squibb | Phase 4 |
| Recruiting | Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach NCT05218811 | Urological Research Network, LLC | N/A |
| Completed | LPN in Patients With High-complex Renal Tumors NCT04933604 | Samsun Liv Hospital | — |
| Withdrawn | Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surg NCT03943771 | University Hospital, Bordeaux | N/A |
| Completed | Three-dimensional Virtual Imaging to Improve the Accuracy of Standard CT-based Nephrometric Scores: a Prospect NCT05729763 | San Luigi Gonzaga Hospital | — |
| Completed | 3D Virtual Models as an Adjunct to Preoperative Surgical Planning NCT03606044 | Dr Eoin R Hyde | — |
| Completed | Laparoscopic Partial Nephrectomy for cT1 Tumors NCT04213157 | Samsun Liv Hospital | — |
| Active Not Recruiting | MRI Functional Imaging Characteristics and Fat Quantification of CT-fat-free Renal Neoplasms: Relationships Wi NCT06126159 | Chang Gung Memorial Hospital | N/A |
| Unknown | Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function NCT03442647 | Thomas Mueller | N/A |
| Withdrawn | The Effect of Pre-treatment Biopsy for Non-neoplastic Renal Disease vs no Biopsy on Estimated Glomerular Filtr NCT02841020 | University of Virginia | N/A |
| Completed | Study of Nivolumab for Advanced Cancers in India NCT03444766 | Bristol-Myers Squibb | Phase 4 |
| Terminated | CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physicia NCT02900248 | CureOne | — |
| Active Not Recruiting | Savolitinib vs. Sunitinib in MET-driven PRCC. NCT03091192 | AstraZeneca | Phase 3 |
| Unknown | Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma NCT03062410 | Centre Hospitalier Universitaire de Besancon | N/A |
| Unknown | Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibi NCT03129724 | University Hospital, Strasbourg, France | — |
| Terminated | A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clea NCT02837991 | Celldex Therapeutics | Phase 1 |
| Completed | Assessment of Oncological and Functional Outcomes After Robot Assisted Partial Nephrectomy Versus Laparoscopic NCT02924922 | Luzerner Kantonsspital | N/A |
| Unknown | Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma Wit NCT02734329 | RenJi Hospital | N/A |
| Unknown | Study to Assess Various Sunitinib Schedules in Renal Cell Carcinoma NCT02689167 | Centre Hospitalier Universitaire de Besancon | Phase 2 |
| Completed | The Pharmacokinetic Variability of Sunitinib in Patients With Metastatic Renal Cancer NCT02404584 | Centre Hospitalier Universitaire de Nīmes | — |
| Terminated | A Study of Varlilumab and Atezolizumab in Patients With Advanced Cancer NCT02543645 | Celldex Therapeutics | Phase 1 |
| Terminated | Early Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune Response NCT02439008 | Centre Oscar Lambret | N/A |
| Terminated | A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma NCT02386111 | Celldex Therapeutics | Phase 1 |
| Completed | IMaging PAtients for Cancer Drug selecTion - Renal Cell Carcinoma (IMPACT-RCC) NCT02228954 | Radboud University Medical Center | — |
| Completed | Evaluation of Complex Renal Cyst With CEUS/Functional MRI Versus CT NCT02371551 | Insel Gruppe AG, University Hospital Bern | — |
| Completed | Study of Safety and Efficacy of Alpelisib With Everolimus or Alpelisib With Everolimus and Exemestane in Advan NCT02077933 | Novartis Pharmaceuticals | Phase 1 |
| Unknown | Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy NCT01892059 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Unknown | Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy NCT01809119 | University of Sao Paulo | N/A |
| Terminated | Imaging Studies of Kidney Cancer Using 18F-VM4-037 NCT01712685 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Cabozantinib for Advanced Urothelial Cancer NCT01688999 | National Cancer Institute (NCI) | Phase 2 |
| Withdrawn | [18]F-Fluciclatide for Kidney Cancer Imaging Studies and Treatment NCT01633255 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy NCT01218854 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Terminated | The Use of Self Retaining Sutures in Open and Laparoscopic Partial Nephrectomy NCT01413607 | Ricardo Rendon | Phase 4 |
| Completed | Level of Expression and Prognostic Value of CXCL4, CXCL4L1 and CXCR3 in Renal Cell Carcinoma NCT01339975 | University Hospital, Bordeaux | — |
| Terminated | Tracking Renal Tumors After Cryoablation Evaluation NCT01117779 | Boston Scientific Corporation | — |
| Completed | Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer NCT00920816 | Pfizer | Phase 3 |
| Unknown | A Clinical Study of the Living Renal Transplantation With Restored Kidneys Between Third Parties NCT00980317 | Tokushukai Medical Group | N/A |
| Terminated | A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer NCT00816686 | Astellas Pharma Inc | Phase 1 |
| Completed | Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer NCT00678392 | Pfizer | Phase 3 |
| Terminated | Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus) NCT00651482 | Sandy Srinivas | Phase 2 |
| Completed | Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI NCT00537056 | Stanford University | N/A |
| Completed | A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At Hig NCT00375674 | Pfizer | Phase 3 |
| Terminated | Evaluation of Diagnostic Value of Molecular Markers in Renal Cancer NCT00491621 | Centre Hospitalier Universitaire de Saint Etienne | N/A |
| Completed | CT Versus CEUS Findings of Complex Cystic Renal Lesions NCT01159717 | University Hospital, Basel, Switzerland | — |
| Completed | Study Of AG-013736 In Patients With Refractory Metastatic Renal Cell Cancer NCT00282048 | Pfizer | Phase 2 |
| Recruiting | Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions NCT03160274 | The University of Texas Health Science Center at San Antonio | — |
| Terminated | Comparison Between Surgery and Radiofrequency for Treatment of Renal Tumors NCT00221728 | University Hospital, Bordeaux | Phase 2 / Phase 3 |
| Unknown | Pilot Study to Develop 3 Tesla MRI for Evaluation of Renal Tumors NCT00507884 | M.D. Anderson Cancer Center | — |
| Completed | Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium NCT00101608 | Bristol-Myers Squibb | Phase 2 |
| Terminated | Cultured White Cells Plus Interleukin-2 to Treat Advanced Kidney Cancer NCT00091611 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer NCT00095108 | ZymoGenetics | Phase 1 |
| Completed | Study of F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Cancers of Low Incidence NCT00123773 | AHS Cancer Control Alberta | Phase 2 |
| Completed | Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma NCT00076011 | Pfizer | Phase 2 |
| Suspended | Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Rena NCT00065572 | AstraZeneca | Phase 2 |
| Completed | Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma NCT00065468 | Pfizer | Phase 3 |
| Completed | The Association of Marital Status With Kidney Cancer Surgery Morbidity NCT05526599 | Beijing Tsinghua Chang Gung Hospital | — |
| Completed | Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer NCT00054886 | Pfizer | Phase 2 |
| Completed | A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell Carcinoma NCT00226980 | Stanford University | Phase 2 |
| Recruiting | Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer NCT00033137 | National Cancer Institute (NCI) | — |
| Completed | A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma NCT00059735 | Eisai Inc. | Phase 2 |
| Completed | EPO906 Therapy in Patients With Advanced Kidney Cancer NCT00035243 | Novartis Pharmaceuticals | Phase 2 |
| Terminated | Von Hippel-Lindau Disease Genetic Epidemiology Study NCT00001803 | National Cancer Institute (NCI) | — |
| Completed | Endolymphatic Sac Tumors in a Population of Patients With Von Hippel-Lindau Disease:The Natural History and Pa NCT00001668 | National Institute of Neurological Disorders and Stroke (NINDS) | — |
| Completed | A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Rena NCT00001570 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study of Motexafin Gadolinium for the Treatment of Renal Cell (Kidney) Cancer NCT00134186 | Pharmacyclics LLC. | Phase 2 |